Cargando…

Immune response characterization of endometrial cancer

BACKGROUND: The comprehensive characterization and prognostic relevance of immune activation in endometrial cancer remain largely unknown. RESULTS: We systematically reported a subset of endometrioid-type endometrial cancer characterized by multifaceted immune features such as low tumor purity, high...

Descripción completa

Detalles Bibliográficos
Autor principal:	Liu, Yuexin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398181/ https://www.ncbi.nlm.nih.gov/pubmed/30847026 http://dx.doi.org/10.18632/oncotarget.26630

Ejemplares similares

Survival correlation of immune response in human cancers
por: Liu, Yuexin
Publicado: (2019)

Clinicopathological correlation of immune response in human cancers
por: Liu, Yuexin
Publicado: (2019)

A global immune gene expression signature for human cancers
por: Liu, Yuexin
Publicado: (2019)

Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment
por: Ma, Jian, et al.
Publicado: (2020)

Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing
por: Guo, Yu-e, et al.
Publicado: (2021)

Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer
por: Chen, Qi, et al.
Publicado: (2015)

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)

Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer
por: Zheng, Mingjun, et al.
Publicado: (2021)

POLE proofreading mutation, immune response and prognosis in endometrial cancer
por: van Gool, Inge C., et al.
Publicado: (2015)

Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
por: Eritja, Núria, et al.
Publicado: (2017)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
por: van der Woude, Hannah, et al.
Publicado: (2022)

Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer
por: Weijiao, Yin, et al.
Publicado: (2021)

Clinical implications of chromatin accessibility in human cancers
por: Liu, Yuexin
Publicado: (2020)

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
por: Vogel, Rachel Isaksson, et al.
Publicado: (2016)

ZAP70 interaction with 13 mRNAs as a potential immunotherapeutic target for endometrial cancer
por: Zhang, Yuming, et al.
Publicado: (2023)

Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer
por: Antill, Yoland, et al.
Publicado: (2021)

Establishment and characterization of novel human primary endometrial cancer cell line (ZJB-ENC1) and its genomic characteristic
por: Liu, Xiaozhen, et al.
Publicado: (2019)

Endometrial histopathology results and evaluation of endometrial cancer risk in geriatric women
por: Günakan, Emre, et al.
Publicado: (2018)

MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
por: Wang, Yingmei, et al.
Publicado: (2016)

Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers
por: Gressel, Gregory M., et al.
Publicado: (2021)

Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
por: Stelloo, Ellen, et al.
Publicado: (2016)

Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer
por: Ma, Jian, et al.
Publicado: (2021)

Integrative analysis of genomic and epigenetic regulation of endometrial cancer
por: Zhong, Qihang, et al.
Publicado: (2020)

Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
por: Bredholt, Geir, et al.
Publicado: (2015)

Analysis of the circular RNA transcriptome in endometrial cancer
por: Chen, Bei Jun, et al.
Publicado: (2017)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Association of benign gynaecological diseases and risk of endometrial and ovarian cancers
por: Shen, Fanghua, et al.
Publicado: (2020)

High expression of TARS is associated with poor prognosis of endometrial cancer
por: Si, Lihui, et al.
Publicado: (2023)

Expression of CD133 in endometrial cancer cells and its implications
por: Ding, Dah-Ching, et al.
Publicado: (2017)

Comprehensive characterization of endometrial competing endogenous RNA network in infertile women of childbearing age
por: Zhang, Meihua, et al.
Publicado: (2020)

BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity
por: Liu, Junxiu, et al.
Publicado: (2022)

Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Laparoscopy or Laparotomy for the Management of Endometrial Cancer
por: Zorlu, C. Gurkan, et al.
Publicado: (2005)

The role of angiogenic factors in endometrial cancer
por: Żyła, Monika Magdalena, et al.
Publicado: (2014)

The significance of markers in the diagnosis of endometrial cancer
por: Żyła, Monika M., et al.
Publicado: (2016)

Factors predicting recurrent endometrial cancer
por: Huijgens, A.N.J., et al.
Publicado: (2013)

Breastfeeding and the incidence of endometrial cancer: A meta-analysis
por: Zhan, Baojian, et al.
Publicado: (2015)

m(6)A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer
por: Li, Kexin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7t03gp8l0ucetofjqu0n56202l